Jonathan Yen Wen Yu Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

Jonathan Yen Wen Yu is Chief Operating Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 40,555 shares of GMTX, which is worth approximately $988,325. The most recent transaction as insider was on Feb 18, 2025, when has been sold 1,610 shares (Common Stock) at a price of $54.58 per share, resulting in proceeds of $87,873. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.6K
123.26% 3M change
123.26% 12M change
Total Value Held $988,325

Jonathan Yen-Wen Yu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2025
SELL
Open market or private sale
$87,873 $54.58 p/Share
1,610 Reduced 3.82%
40,555 Common Stock
Feb 10 2025
BUY
Grant, award, or other acquisition
-
24,000 Added 36.27%
42,165 Common Stock
Jan 10 2024
BUY
Grant, award, or other acquisition
-
18,165 Added 50.0%
18,165 Common Stock
JYY

Jonathan Yen Wen Yu

Chief Operating Officer
Watertown, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX